Sanofi-Genzyme: BioMarin to Win, NPS Next Tempter?
"Change of control." It's one of those legal phrases in a contract that, when brought into play, can strike terror or joy into the heart of one side of a partnership or another who might have more casually agreed years earlier. The concept could take center stage for BioMarin Pharmaceutical Inc. in the firm's deal with Genzyme Corp. if Sanofi-Aventis SA goes ahead with a persistent bid to take over Cambridge, Mass.-based Genzyme Corp. a bid that speculators predicted could turn hostile.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter